Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 5/20 | 0.90 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.90 |
| ▸ | F10 | P00742 | 2/20 | 0.90 |
| ▸ | LMNA | P02545 | 1/20 | 0.90 |
| ▸ | PLAT | P00750 | 1/20 | 0.90 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.90 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Argatroban SCHEMBL22974994 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL20567702 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL18895186 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL4375 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL29741503 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL135173 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL15019460 | 0.95 | F2 (1.00) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL20787652 | 0.94 | F2 (0.99) | F2PRSS1F10LMNAPLAT | |
| Argatroban SCHEMBL29618936 | 0.94 | F2 (0.99) | F2PRSS1F10LMNAPLAT | |
| SCHEMBL18584076 | 0.88 | F2 (0.74) | F2PRSS1F10LMNAPLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017471-A1 | FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS | UNIV SHANGHAI TECHNOLOGY (CN) | 2022-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017471-A1 | FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS | PAICS, PFAS, OTC | F2 799/4885PRSS1 4830/4885F10 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.